about
Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's Disease.Huperzine A activates Wnt/β-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse modelNeurobiology of butyrylcholinesterase.7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer's Disease Treatment.Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's diseaseAmyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs.Current therapies and new strategies for the management of Alzheimer's disease.Na⁺-K⁺-ATPase, a potent neuroprotective modulator against Alzheimer disease.Stem-cell challenges in the treatment of Alzheimer's disease: a long way from bench to bedside.Neuritic and Diffuse Plaque Associations with Memory in Non-Cognitively Impaired Elderly.The Emerging Therapeutic Role of NGF in Alzheimer's Disease.Butyrylcholinesterase: impact on symptoms and progression of cognitive impairment.Three-way interaction model to trace the mechanisms involved in Alzheimer's disease transgenic miceThioesters for the in vitro evaluation of agents to image brain cholinesterases.Human butyrylcholinesterase components differ in aryl acylamidase activity.Neuroprotective Role of Novel Triazine Derivatives by Activating Wnt/β Catenin Signaling Pathway in Rodent Models of Alzheimer's Disease.Discovery of novel isoflavone derivatives as AChE/BuChE dual-targeted inhibitors: synthesis, biological evaluation and molecular modelling.Streptozotocin Induced Neurotoxicity Involves Alzheimer's Related Pathological Markers: a Study on N2A Cells.Computational studies of acetylcholinesterase complexed with fullerene derivatives: a new insight for Alzheimer disease treatment.Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease.Using evolutionary tools to search for novel psychoactive plantsScale Alpha and Beta of Quantitative Convergence and Chemical Reactivity Analysis in Dual Cholinesterase/Monoamine Oxidase Inhibitors for the Alzheimer Disease Treatment Using Density Functional Theory (DFT)
P2860
Q33708963-AB036799-6704-4A5B-A565-56C05E5F4854Q34797526-E3A03B4C-5CF7-4711-B481-E19503A2AE3DQ35058510-703C66AD-E1F4-41A0-9AA8-FF4D3427F152Q35874432-FFF9D346-34BB-4C5E-9CD8-5A20308416ADQ36601142-1055F867-FDD1-4206-9449-24BE7A0F55EEQ37104891-0C3C02B4-DBF2-4053-8687-A0D08B4ECC4CQ37770005-56DD2727-62F9-490B-8E3B-39F58E4E43D5Q38049179-22A2017F-A86E-42DD-9783-1F2F49C565A1Q38185612-7E1A1152-25A2-4340-9997-3CD6289C6AE4Q38388660-4270ACCF-69A0-470C-A51D-47506241C4BFQ38708387-40E8B7FB-4C47-432A-AE6C-4B0BE7800981Q40427878-9F988BE7-0B72-4484-928F-67158CCF41C6Q41876717-06EA1CD5-64BB-4626-9374-03D39CDB9F8CQ44322285-A2F6739C-EE76-4402-A8EC-DE878FB0134FQ46799104-80BAB1D9-14E2-4257-ADAB-F3D8D3459F15Q46833725-CAD8BEBC-5305-4712-8FE0-45A117C1CABBQ48190884-78323510-01E0-41B7-AEDE-90F618F88575Q48255292-7CC8418E-A4D4-46A9-A21D-93D2CC6072D8Q51830395-7FE16B2E-31BF-4E46-98D1-A98791A10DCDQ53254173-87FEC1EB-0114-4971-B646-934FC65246B7Q57429531-28BAA8EB-D477-4D50-BAF7-F44779D0033EQ59022312-D3ACF8D0-46A5-4C79-B5CB-D735630DE61B
P2860
description
1995 nî lūn-bûn
@nan
1995 թուականին հրատարակուած գիտական յօդուած
@hyw
1995 թվականին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Cholinesterases and the Pathology of Alzheimer Disease
@ast
Cholinesterases and the Pathology of Alzheimer Disease
@en
Cholinesterases and the Pathology of Alzheimer Disease
@en-gb
type
label
Cholinesterases and the Pathology of Alzheimer Disease
@ast
Cholinesterases and the Pathology of Alzheimer Disease
@en
Cholinesterases and the Pathology of Alzheimer Disease
@en-gb
prefLabel
Cholinesterases and the Pathology of Alzheimer Disease
@ast
Cholinesterases and the Pathology of Alzheimer Disease
@en
Cholinesterases and the Pathology of Alzheimer Disease
@en-gb
P921
P1476
Cholinesterases and the Pathology of Alzheimer Disease
@en
P2093
Changiz Geula
M. -Marsel Mesulam
P356
10.1097/00002093-199501002-00005
P407
P577
1995-01-01T00:00:00Z